Treatment with Tumor-Treating Fields therapy and pulse dose bevacizumab in patients with bevacizumab-refractory recurrent glioblastoma: A case series.

Authors

George Ansstas, Washington University School of Medicine in St. Louis
David D. Tran, Washington University School of Medicine in St. Louis

Journal

Case Reports in Neurology

Publication Date

2016

Volume

8

Issue

1

Inclusive Pages

1-9

Document Type

Open Access Publication

DOI

10.1159/000442196

Rights and Permissions

Ansstas, G., & Tran, D. D. (2016). Treatment with tumor-treating fields therapy and pulse dose bevacizumab in patients with bevacizumab-refractory recurrent glioblastoma: A case series. Case Reports in Neurology, 8(1), 1-9. doi:10.1159/000442196 Copyright 2016 The Author(s) Published by S. Karger AG, Basel 1662‒680X/16/0081‒0001$39.50/0 www.karger.com/crn This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. The final, published version of this article is available at http://www.karger.com/?doi=10.1159/000442196

Recommended Citation

Ansstas, George and Tran, David D., "Treatment with Tumor-Treating Fields therapy and pulse dose bevacizumab in patients with bevacizumab-refractory recurrent glioblastoma: A case series.." Case Reports in Neurology. 8, 1. 1-9. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5782